title: Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?
abstract: We recently conducted several studies regarding the presence of high-risk HPVs in human cervical, colorectal and breast cancers in the Syrian population. Herein, we report that high-risk HPVs type 16, 18, 33, 45, 51, 52 and 58 are frequently present in colorectal cancer in this population. Therefore and based on previous studies and present data, we conclude that the most frequent high-risk HPV types, in the Syrian population, are 16, 18, 33, 35, 45, 51, 52 and 58. Thus, our data suggest that it will be useful to use the new generation of HPV vaccine to protect the Syrian population from high-risk HPVs and their associated cancers.
authors.affiliation: Syrian Research Cancer Centre of the Syrian Society against Cancer; Aleppo, Syria.
authors.forename: Ala-Eddin
authors.initials: AE
authors.lastname: Al Moustafa
authors.forename: Amber
authors.initials: A
authors.lastname: Yasmeen
authors.forename: Lina
authors.initials: L
authors.lastname: Ghabreau
authors.forename: Nizar
authors.initials: N
authors.lastname: Akil
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*; D005260:Female; D005838:Genotype; D006801:Humans; D027383:Papillomaviridae / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D013593:Syria / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology*
chemical_list: D053918:Papillomavirus Vaccines